Research Solutions (RSSS) 10-Q 7 Feb 14 2014 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Dec. 31, 2013	Jan. 27, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Dec-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Trading Symbol	'RSSS	'
Entity Common Stock, Shares Outstanding	'	17,554,729
Entity Registrant Name	'Research Solutions, Inc.	'
Entity Central Index Key	'0001386301	'
Current Fiscal Year End Date	'--06-30	'
Entity Filer Category	'Smaller Reporting Company	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Jun. 30, 2013
Current assets:	'	'
Cash and cash equivalents	$2,074,600	$1,699,969
Accounts receivable:	'	'
Trade receivables, net of allowance of $224,091 and $211,743, respectively	5,609,223	4,966,717
Due from factor	12,434	165,971
Inventory	158,780	171,682
Prepaid expenses and other current assets	335,049	327,532
Prepaid royalties	900,260	351,852
Total current assets	9,090,346	7,683,723
Other assets:	'	'
Property and equipment, net of accumulated depreciation of $1,327,708 and $1,094,953, respectively	699,686	831,231
Intangible assets, net of accumulated amortization of $357,955 and $308,245, respectively	89,410	123,482
Deposits and other assets	480,067	286,073
Total assets	10,359,509	8,924,509
Current liabilities:	'	'
Accounts payable and accrued expenses	8,423,076	7,530,034
Capital lease obligations, current	319,075	221,461
Notes payable, current	46,808	55,293
Due to factor	171,415	246,221
Deferred revenue	429,339	53,216
Total current liabilities	9,389,713	8,106,225
Long term liabilities:	'	'
Notes payable, long term	0	11,059
Capital lease obligations, long term	280,574	493,045
Total liabilities	9,670,287	8,610,329
Commitments and contingencies	'	'
Stockholders’ equity:	'	'
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 17,554,729 and 16,970,465 shares issued and outstanding, respectively	17,555	16,970
Additional paid-in capital	15,234,926	14,213,443
Accumulated deficit	-14,581,741	-13,992,238
Accumulated other comprehensive income	18,482	76,005
Total stockholders’ equity	689,222	314,180
Total liabilities and stockholders’ equity	$10,359,509	$8,924,509

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Dec. 31, 2013	Jun. 30, 2013
Trade receivables, allowance	$224,091	$211,743
Property and equipment, accumulated depreciation	1,327,708	1,094,953
Intangible Assets, accumulated amortization	$357,955	$308,245
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	17,554,729	16,970,465
Common stock, shares outstanding	17,554,729	16,970,465

Consolidated_Statements_of_Ope

Consolidated Statements of Operations and Other Comprehensive Income (Loss) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Revenue	$9,622,379	$13,982,098	$18,200,100	$23,524,097
Cost of revenue	7,402,073	11,223,397	13,974,818	18,608,552
Gross profit	2,220,306	2,758,701	4,225,282	4,915,545
Operating expenses:	'	'	'	'
Selling, general and administrative	2,521,246	2,414,701	4,532,275	4,405,411
Depreciation and amortization	120,964	134,914	238,315	321,572
Gain on sale of fixed assets	0	0	0	-6,879
Total operating expenses	2,642,210	2,549,615	4,770,590	4,720,104
Income (loss) from operations	-421,904	209,086	-545,308	195,441
Other income (expenses)	'	'	'	'
Interest expense	-15,278	-22,723	-27,925	-59,560
Other income (expense)	-7,175	-6,956	-6,389	-9,914
Total other expense	-22,453	-29,679	-34,314	-69,474
Income (loss) before provision for income taxes	-444,357	179,407	-579,622	125,967
Provision for income taxes	-2,199	-1,088	-9,881	-1,681
Net income (loss)	-446,556	178,319	-589,503	124,286
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation	-20,549	-37,603	-57,523	-65,250
Comprehensive income (loss)	($467,105)	$140,716	($647,026)	$59,036
Net income (loss) per share:	'	'	'	'
Basic	($0.03)	$0.01	($0.03)	$0.01
Diluted	($0.03)	$0.01	($0.03)	$0.01
Weighted average shares outstanding:	'	'	'	'
Basic	17,171,633	17,208,117	17,071,049	17,145,856
Diluted	17,171,633	17,208,117	17,071,049	17,175,663

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (Deficiency) (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Jun. 30, 2013	$314,180	$16,970	$14,213,443	($13,992,238)	$76,005
Balance (in shares) at Jun. 30, 2013	'	16,970,465	'	'	'
Fair value of vested stock options	131,678	0	131,678	0	0
Fair value of common stock issued for services	52,390	166	52,224	0	0
Fair value of common stock issued for services (in shares)	'	165,264	'	'	'
Common shares issued upon exercise of warrants (in shares)	'	419,000	'	'	'
Common shares issued upon exercise of warrants	838,000	419	837,581	0	0
Net loss for the period	-589,503	0	0	-589,503	0
Foreign currency translation	-57,523	0	0	0	-57,523
Balance at Dec. 31, 2013	$689,222	$17,555	$15,234,926	($14,581,741)	$18,482
Balance (in shares) at Dec. 31, 2013	'	17,554,729	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flow from operating activities:	'	'
Net income (loss)	($589,503)	$124,286
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Depreciation and amortization	238,315	343,815
Fair value of vested stock options	131,678	110,406
Fair value of common stock issued for services	52,390	0
Gain on sale of fixed assets	0	-6,879
Changes in assets and liabilities:	'	'
Accounts receivable	-642,506	-2,773,262
Inventory	12,902	11,718
Due from factor	153,537	-63,604
Prepaid expenses and other current assets	-7,517	-590,644
Prepaid royalties	-548,408	13,779
Deposits and other assets	-193,994	-2,913
Accounts payable and accrued expenses	893,042	3,677,225
Deferred revenue	376,123	257,474
Net cash provided by (used in) operating activities	-123,941	1,101,401
Cash flow from investing activities:	'	'
Purchase of property and equipment	-20,359	-61,810
Purchase of intangible assets	-15,638	0
Proceeds from sale of fixed assets	0	16,357
Net cash used in investing activities	-35,997	-45,453
Cash flow from financing activities:	'	'
Payments to factor	-74,806	-8,860
Payment of notes payable	-19,544	-28,263
Payment of capital lease obligations	-114,857	-262,845
Payments under line of credit	0	-900,000
Issuance of shares upon exercise of warrants for cash	838,000	0
Net cash provided by (used in) financing activities	628,793	-1,199,968
Effect of exchange rate changes	-94,224	-108,673
Net increase (decrease) in cash and cash equivalents	374,631	-252,693
Cash and cash equivalents, beginning of period	1,699,969	3,150,978
Cash and cash equivalents, end of period	2,074,600	2,898,285
Supplemental disclosures of cash flow information:	'	'
Cash paid for income taxes	9,881	1,681
Cash paid for interest	27,925	59,560
Supplemental disclosures of non-cash investing and financing activities:	'	'
Acquisition of customer list through issuance of common shares	$0	$154,908

Organization_Nature_of_Busines

Organization, Nature of Business and Basis of Presentation	6 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	Note 1.  Organization, Nature of Business and Basis of Presentation
	Organization
	Research Solutions, Inc. (the “Company,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006.  On March 4, 2013, the Company consummated a merger with DYSC Subsidiary Corporation, the Company’s wholly-owned subsidiary, pursuant to which the Company, in connection with such merger, amended its Articles of Incorporation to change its name to Research Solutions, Inc. (formerly Derycz Scientific, Inc.). Research Solutions, Inc. is a publicly traded holding company with three wholly owned subsidiaries: Reprints Desk, Inc., a Delaware corporation (“Reprints Desk”); Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico (“Reprints Desk Latin America”); and Techniques Appliquées aux Arts Graphiques, S.p.A. (“TAAG”), an entity organized under the laws of France.
	Nature of Business
	We provide research solutions that facilitate the flow of information from the publishers of scientific, technical, and medical (“STM”) content to enterprise customers in life science and other research intensive organizations around the world. We provide customers with access to hundreds of thousands of newly published articles each year in addition to the tens of millions of existing articles that have been published in the past, helping them to identify the most useful and relevant content for their activities. In addition to serving end users of content, we also serve STM publishers by facilitating compliance with applicable copyright laws. We have developed proprietary software and Internet-based interfaces that allow customers to find, electronically receive and legally use the content that is critical to their research.
	We have two reportable diverse geographical concentrations:  North American Operations, which consists of Reprints Desk and Reprints Desk Latin America, and TAAG, which operates in France.
	We provide three types of solutions to our customers: research solutions, marketing solutions, and printing solutions.
	Research Solutions
	Researchers and regulatory personnel in life science and other research intensive organizations generally require single copies of published STM journal articles for use in their research activities. They place orders with us for the articles they need and we source and electronically deliver the requested content to them generally in under an hour. This service is known in the industry as single article delivery or document delivery. We also obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. We have non-exclusive arrangements with numerous content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Even though single article delivery services are charged on a transactional basis, customer order volume tends to be consistent from month to month in part due to consistent orders of larger customers that require the implementation of our services into their work flow.
	We have developed proprietary software and Internet-based interfaces that allow customers to initiate orders, manage transactions, obtain reporting, automate authentication, improve seamless connectivity to corporate intranets, and enhance the information resources they already own, or have access to via subscriptions or internal libraries, as well as organize workgroups to collaborate around scientific information. In some cases, our proprietary software allows us to fully automate the order fulfillment process. Our services alleviate the need for our customers to develop internal systems or contact multiple content publishers in order to obtain the content that is critical to their research. We also help customers connect to free content on the Internet when available and compliant with applicable copyright laws.
	All of the aforementioned services and proprietary software comprise the Article Galaxy journal article platform (“Article Galaxy”).
	Marketing Solutions
	Marketing departments in life science and other research intensive organizations generally require large quantities of printed copies of published STM journal articles called “Reprints.” They generally supply Reprints to doctors who may prescribe their products and at conferences. We obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. The majority of content publishers print their content in-house and prohibit others from printing their content, however, when not prohibited by the content publisher, we use a third party to print Reprint orders delivered to North American customers, and TAAG to print Reprint orders delivered to mostly European customers. Electronic copies, called “ePrints,” are also used for distribution through the Internet and other electronic mechanisms. We have developed proprietary ePrint software that increase the efficiency of our customers’ content purchases by transitioning from paper reprints to electronic ePrints, and by improving compliance with applicable copyright laws and promotional regulations within the life sciences industry. Reprints and ePrints are charged on a transactional basis and order volume typically fluctuates from month to month based on customer marketing budgets and the existence of STM journal articles that fit customer requirements.
	Printing Solutions
	Our printing solutions, exclusively performed by TAAG, our French operating subsidiary, include a variety of hard copy, professionally printed materials that are used for retail and marketing purposes, including Reprints, as well as regulatory sensitive marketing materials and clinical trial kits. The majority of TAAG’s customers are in France. Only a small percentage of the printing work performed by TAAG is for Reprint orders for North American operations delivered to mostly European customers.
	Liquidity
	Historically, we have relied upon cash from financing activities to fund substantially all of the cash requirements of our activities and have incurred significant losses and experienced negative cash flow. As of December 31, 2013, we had an accumulated deficit of $14,581,741 and stockholders’ equity of $689,222. For the six months ended December 31, 2013, the Company recorded a net loss of $589,503 and cash used in operating activities was $123,941. We cannot predict if we will be profitable. We may continue to incur losses for an indeterminate period of time and may never sustain profitability. An extended period of losses and negative cash flow may prevent us from successfully operating and expanding our business. We may be unable to achieve and maintain profitability on a quarterly or annual basis.
	North American Operations (Reprints Desk and Reprints Desk Latin America)
	The Company believes that its current cash resources and expected cash flow from our North American operations will be sufficient to sustain current North American operations for the next twelve months.   The Company expects that cash flow from our North American operating activities will continue to be positive; however, there are no assurances that such results will be achieved.
	TAAG (France)
	The Company believes that its current cash resources and expected cash flow from TAAG may not be sufficient to sustain TAAG operations for the next twelve months.   During the six months ended December 31, 2013, TAAG incurred a net loss from operations of $2,268, and at December 31, 2013, had a working capital deficiency of approximately $1,630,000.  In addition, significant net losses in prior years have been incurred and approximately $325,000 of payroll and VAT taxes were delinquent at December 31, 2013.  Effective June 30, 2013, the Company forgave a loan receivable from TAAG totaling $1,009,115 to improve TAAG’s liquidity.  The Company’s line of credit with Silicon Valley Bank limits the amount of funding of TAAG to a maximum of $279,333.  The funding period for TAAG under the line of credit expires on March 31, 2014, and no additional financing for TAAG is in place.  In the event that TAAG liquidates our exposure to creditors in France is limited to the assets of TAAG, with the exception of a $50,000 guarantee by the Company in favor of the landlord on the facility lease.  In the event that TAAG liquidates we would lose a significant percentage of revenue, or all revenue, from TAAG.
	Principles of Consolidation
	The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.
	Basis of Presentation
	The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013 filed with the SEC. The condensed consolidated balance sheet as of June 30, 2013 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.
	In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	Note 2.  Summary of Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.
	These estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer's financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required.
	Cash denominated in Euros with a US Dollar equivalent of $559,239 and $393,093 at December 31, 2013 and June 30, 2013, respectively, was held in accounts at financial institutions located in Europe.
	The following table summarizes accounts receivable concentrations:
		As of December 31,			As of June 30,
		2013			2013
	Customer A	23	%		11	%
	The following table summarizes revenue concentrations:
		Three Months Ended						Six Months Ended
		December 31,						December 31,
		2013			2012			2013		2012
	Customer A	21	%		23	%		16	%	16	%
	The following table summarizes vendor concentrations:
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Vendor A	28	%	26	%	21	%	22	%
	Vendor B		*	30	%		*	22	%
	Vendor C		*		*	12	%		*
	Vendor D		*		*	11	%		*
	* Less than 10%
	Revenue Recognition
	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing three types of services to our customers: Article Galaxy, Reprints and ePrints, and Printing and Logistics services.
	Article Galaxy
	We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. The Company recognizes revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Reprints and ePrints
	We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content, however, when not prohibited by the content publisher, we use a third party to print Reprint orders delivered to North American customers, and TAAG to print Reprint orders delivered to mostly European customers. The Company recognizes revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Printing and Logistics Services
	We charge a transactional fee for each order of hard copy printed material. We are responsible for printing and delivering the order. Printing and Logistics services are exclusively performed by TAAG, our French operating subsidiary. The majority of TAAG’s customers are in France. Only a small percentage of the printing work performed by TAAG is for Reprint orders for North American operations delivered to mostly European customers. The Company recognizes revenue from printing services when the printed materials have been shipped to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Stock-Based Compensation
	The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations.  The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete.  Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
	Foreign Currency Translation
	The accompanying condensed consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the revenues and costs of TAAG are in Euros, and the costs of Reprints Desk Latin America are in Mexican pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.
	Net Income (Loss) Per Share
	Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock.  Diluted net income per share is computed similar to basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive securities had been issued.  Potentially dilutive securities include stock options and warrants.  The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.
	Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, excluding unvested restricted common stock.  Basic and diluted net loss per common share is the same for all periods presented with a net loss because all warrants and stock options outstanding are anti-dilutive.
	The calculation of basic and diluted net income (loss) per share is presented below:
		Three Months Ended						Six Months Ended
		December 31,						December 31,
		2013			2012			2013		2012
	Numerator:
	Net income (loss)	$	-446,556		$	178,319		$	-589,503	$	124,286
	Denominator:
	Weighted average shares outstanding (basic)		17,171,633			17,208,117			17,071,049		17,145,856
	Effect of diluted securities		-			-			-		29,807
	Weighted average shares outstanding (diluted)		17,171,633			17,208,117			17,071,049		17,175,663
	Net income (loss) per share:
	Basic	$	-0.03		$	0.01		$	-0.03	$	0.01
	Diluted	$	-0.03		$	0.01		$	-0.03	$	0.01
	Recently Issued Accounting Pronouncements
	In March 2013, the FASB issued ASU 2013-05 Topic 830, “Foreign Currency Matters” (“ASU 2013-05”). ASU 2013-05 resolves the diversity in practice about whether Subtopic 810-10, Consolidation—Overall, or Subtopic 830-30, ASU 2013-05 applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) within a foreign entity. In addition, the amendments in this update resolve the diversity in practice for the treatment of business combinations achieved in stages (sometimes also referred to as step acquisitions) involving a foreign entity. ASU 2013-02 became effective for the company prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The Company does not expect the adoption of this guidance to have a material effect on the Company’s unaudited condensed consolidated financial statements.
	The FASB has issued Accounting Standards Update (ASU) No. 2013-04, Liabilities (Topic 405), “Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date.” ASU 2013-04 provides guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this ASU is fixed at the reporting date, except for obligations addressed within existing guidance in GAAP. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The Company does not expect the adoption of this guidance to have a material impact on the Company’s unaudited condensed consolidated financial statements.
	In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists (A Consensus of the FASB Emerging Issues Task Force). ASU 2013-11 provides guidance on financial statement presentation of unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The FASB’s objective in issuing this ASU is to eliminate diversity in practice resulting from a lack of guidance on this topic in current GAAP. This ASU applies to all entities with unrecognized tax benefits that also have tax loss or tax credit carryforwards in the same tax jurisdiction as of the reporting date. This amendment is effective for public entities for fiscal years beginning after December 15, 2013 and interim periods within those years. The Company does not expect the adoption of this standard to have a material impact on the Company’s unaudited condensed consolidated financial position and results of operations.
	Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Line_of_Credit

Line of Credit	6 Months Ended
	Dec. 31, 2013
Line Of Credit Facility [Abstract]	'
Line Of Credit Facility Disclosure [Text Block]	'
	Note 3.  Line of Credit
	The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $4,000,000, or 80% of eligible accounts receivable.  The line of credit matures on October 31, 2015, and is subject to certain financial and performance covenants with which we were in compliance as of December 31, 2013. Financial covenants are measured on North American operations only and include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2013, plus 50% of the dollar value of equity issuances after October 1, 2013 (reduced to 40% of the dollar value of equity issuances in connection with the exercise of warrants in November 2013) and the principal amount of subordinated debt. The Company failed to comply with the tangible net worth covenant in December 2011 and July 2013. On both occasions the parties agreed to amend and reset the minimum tangible net worth required under the covenant. The line of credit bears interest at the prime rate plus 2.5% for periods in which the Company maintains an account balance with SVB (less all indebtedness owed to SVB) of at least $800,000 at all times during the prior calendar month (the “Streamline Period”), and at the prime rate plus 5.25% when a Streamline Period is not in effect. The interest rate on the line of credit was 6.5% as of December 31, 2013. The line of credit is secured by all of the Company’s and its subsidiaries’ assets, excluding TAAG’s assets.
	There were no outstanding borrowings under the line as of December 31, 2013 and June 30, 2013, respectively.  As of December 31, 2013 and June 30, 2013, approximately $2,300,000 and $2,000,000, respectively, of available credit was unused under the line of credit.

Factor_Agreements

Factor Agreements	6 Months Ended
	Dec. 31, 2013
Factor Agreements [Abstract]	'
Significant Agreements Disclosure [Text Block]	'
	Note 4.  Factor Agreements
	The Company, through TAAG, has factoring agreements with Credit Cooperatif and Natixis for working capital and credit administration purposes.  Under the agreements, the factors purchase trade accounts receivable assigned to them by the Company.  The accounts are sold (with recourse) at the invoice amount subject to a factor commission and other miscellaneous fees.  Trade accounts receivable not sold remain in the Company's custody and control and the Company maintains all credit risk on those accounts.
	On September 10, 2013, the Company terminated its factoring agreement with ABN Amro.  As of December 31, 2013 and June 30, 2013, $0 and $165,971 was due from ABN Amro, respectively.
	Under the factoring agreement with Credit Cooperatif, the Company can borrow up to approximately $325,000 (Euro 250,000).  The factor fee is determined on a case by case basis and is not specified in the agreement.  The fee charged for the obligations outstanding as of December 31, 2013 was approximately 5%.  As of December 31, 2013 and June 30, 2013, $171,415 and $246,221 was due to Credit Cooperatif, respectively, that relate to funds paid to the Company not yet returned to the factor.
	On May 3, 2013, the Company entered into a factoring agreement with Natixis. The maximum amount the Company can borrow is not specified in the agreement.  The factor fee is determined based on the Company's revenue and the average amount of customer invoices.  The fee charged for the obligations outstanding as of December 31, 2013 was approximately 0.45%.  In addition, interest is charged on the amount financed at the three month Euribor interest rate plus 1.6%. The interest rate under the agreement was approximately 1.8% per annum at December 31, 2013.  As of December 31, 2013 and June 30, 2013, $12,434 and $0 was due from Natixis, respectively.

Stockholders_Equity

Stockholders' Equity	6 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	Note 5.  Stockholders’ Equity
	Stock Options
	In December 2007, we established the 2007 Equity Compensation Plan (the “Plan”). The Plan was approved by our board of directors and stockholders. The purpose of the Plan is to grant stock and options to purchase our common stock to our employees, directors and key consultants. On November 15, 2012, the maximum number of shares of common stock that may be issued pursuant to awards granted under the Plan increased from 1,500,000 to 3,000,000, as approved by our board of directors and stockholders.  Cancelled and forfeited stock options and stock awards may again become available for grant under the Plan. There were 833,841 shares available for grant under the Plan as of December 31, 2013. All current stock option grants are made under the 2007 Equity Compensation Plan.
	The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period.
	The following table summarizes vested and unvested stock option activity:
			All Options						Vested Options					Unvested Options
			Shares			Weighted			Shares			Weighted		Shares		Weighted
						Average						Average				Average
						Exercise						Exercise				Exercise
						Price						Price				Price
	Outstanding at June 30, 2013			1,692,898			1.24			1,352,730			1.23		340,168		1.29
	Granted			191,472			1.8			7,400			1.8		184,072		1.8
	Options vesting			-			-			56,834			1.41		-56,834		1.41
	Exercised			-			-			-			-		-		-
	Forfeited/Cancelled			-			-			-			-		-		-
	Outstanding at December 31, 2013			1,884,370		$	1.3			1,416,964		$	1.24		467,406	$	1.48
	The weighted average remaining contractual life of all options outstanding as of December 31, 2013 was 6.92 years.  The weighted average remaining contractual life for options vested and exercisable at December 31, 2013 was 6.17 years.  Furthermore, the aggregate intrinsic value of all options outstanding as of December 31, 2013 was $1,354,438, and the aggregate intrinsic value of options vested and exercisable at December 31, 2013 was $1,109,248, in each case based on the fair value of the Company’s common stock on December 31, 2013.  The total fair value of options vested during the six months ended December 31, 2013 was $131,678 and is included in selling, general and administrative expenses in the accompanying statement of operations.  As of December 31, 2013, the amount of unvested compensation related to these options was $407,706 which will be recorded as an expense in future periods as the options vest.
	Additional information regarding stock options outstanding and exercisable as of December 31, 2013 is as follows:
	Option			Options			Remaining			Options
	Exercise			Outstanding			Contractual			Exercisable
	Price						Life (in years)
	$	1			347,000			5.41			347,000
		1.02			287,000			6.58			287,000
		1.07			53,898			8.79			42,231
		1.15			278,000			9.11			150,000
		1.25			32,000			9.13			-
		1.3			263,000			8.18			175,333
		1.5			380,000			4.06			380,000
		1.8			190,050			9.73			7,400
		1.85			24,000			9.39			-
		1.97			1,422			9.9			-
		3			15,000			7.04			15,000
		3.05			10,000			7.12			10,000
		3.65			3,000			7.22			3,000
	Total				1,884,370						1,416,964
	Warrants
	The following table summarizes warrant activity:
			Number of			Weighted
			Warrants			Average
						Exercise
						Price
	Outstanding, June 30, 2013			2,376,173			2.06
	Granted			-			-
	Exercised			-419,000			2
	Expired			-662,175			2
	Outstanding, December 31, 2013			1,294,998		$	2.11
	Exercisable, June 30, 2013			2,376,173		$	2.06
	Exercisable, December 31, 2013			1,294,998		$	2.11
	The intrinsic value for all warrants outstanding as of December 31, 2013 was $317,333, based on the fair value of the Company’s common stock on December 31, 2013.
	In November 2013, warrant holders exercised warrants to purchase 419,000 shares of the Company’s common stock for $838,000.
	Additional information regarding warrants outstanding and exercisable as of December 31, 2013 is as follows:
	Warrant			Warrants			Remaining			Warrants
	Exercise Price			Outstanding			Contractual			Exercisable
							Life (in years)
	$	1.19			150,000			7.98			150,000
		1.25			150,000			1.85			150,000
		1.75			333,331			0.89			333,331
		2.25			266,667			0.97			266,667
		3			390,000			0.12			390,000
		3.5			2,500			2.5			2,500
		4			2,500			2.5			2,500
	Total				1,294,998						1,294,998
	Restricted Common Stock
On September 6, 2013, the Company issued 150,833 shares of restricted common stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $271,499 based on the market price of our common stock of $1.80 per share on the date of grant, which will be amortized over the three year vesting period.
On November 22, 2013, the Company issued 11,683 shares of restricted common stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $23,016 based on the market price of our common stock of $1.97 per share on the date of grant, which will be amortized over the three year vesting period.
The total fair value of restricted common stock vested during the six months ended December 31, 2013 was $47,168 and is included in selling, general and administrative expenses in the accompanying statement of operations. As of December 31, 2013, the amount of unvested compensation related to this issuance of restricted common stock was $247,347 which will be recorded as an expense in future periods as the stock vests. When calculating net income (loss) per share, these shares are included in weighted average common shares outstanding from the time they vest.
The following table summarizes restricted common stock activity:
		Number of			Weighted
		Shares			Average
					Grant Date
					Fair Value
Non-vested, June 30, 2013			33,939			1.85
Granted			162,516			1.81
Vested			-			-
Forfeited			-			-
Non-vested, December 31, 2013			196,455		$	1.82
Issuance of Common Stock
On December 6, 2013, the Company issued 2,748 shares of common stock valued at $5,222 to a consultant for services rendered.

Geographical_Information

Geographical Information	6 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	Note 6.  Geographical Information
	As of December 31, 2013, the Company had two reportable diverse geographical concentrations:  North American Operations, which consists of Reprints Desk and Reprints Desk Latin America, and TAAG, which operates in France.  Information related to these operating segments, net of eliminations, consists of the following for the periods below:
		Three Months Ended						Six Months Ended
		December 31, 2013						December 31, 2013
		North						North
		American		TAAG				American		TAAG
		Operations		(France)		Total		Operations		(France)		Total
	Revenue	$	7,383,148	$	2,239,231	$	9,622,379	$	14,000,578	$	4,199,522	$	18,200,100
	Cost of revenue		6,067,698		1,334,375		7,402,073		11,487,425		2,487,393		13,974,818
	Selling, general and administrative expenses		1,718,559		802,687		2,521,246		2,957,872		1,574,403		4,532,275
	Depreciation and amortization		50,770		70,194		120,964		98,321		139,994		238,315
	Income (loss) from operations	$	-453,879	$	31,975	$	-421,904	$	-543,040	$	-2,268	$	-545,308
		Three Months Ended						Six Months Ended
		December 31, 2012						December 31, 2012
		North		TAAG		Total		North		TAAG		Total
		American		(France)				American		(France)
		Operations						Operations
	Revenue	$	11,544,064	$	2,438,034	$	13,982,098	$	18,647,223	$	4,876,874	$	23,524,097
	Cost of revenue		9,848,155		1,375,242		11,223,397		15,685,344		2,923,208		18,608,552
	Selling, general and administrative expenses		1,242,750		1,171,951		2,414,701		2,365,597		2,039,814		4,405,411
	Depreciation and amortization		43,191		91,723		134,914		137,467		184,105		321,572
	Gain on sale of fixed assets		-		-		-		-8,500		1,621		-6,879
	Income (loss) from operations	$	409,968	$	-200,882	$	209,086	$	467,315	$	-271,874	$	195,441
		As of December 31, 2013						As of June 30, 2013
		North						North
		American		TAAG				American		TAAG
		Operations		(France)		Total		Operations		(France)		Total
	Current assets	$	6,835,895	$	2,254,451	$	9,090,346	$	5,536,474	$	2,147,249	$	7,683,723
	Property and equipment, net		145,057		554,629		699,686		189,596		641,635		831,231
	Intangible assets, net		89,410		-		89,410		123,482		-		123,482
	Other non-current assets		9,698		470,369		480,067		9,712		276,361		286,073
	Total assets	$	7,080,060	$	3,279,449	$	10,359,509	$	5,859,264	$	3,065,245		8,924,509
	Current liabilities	$	5,504,817	$	3,884,896	$	9,389,713	$	4,732,746	$	3,373,479		8,106,225
	Long term liabilities		-		280,574		280,574		-		504,104		504,104
	Equity		1,575,243		-886,021		689,222		1,126,518		-812,338		314,180
	Total liabilities and equity	$	7,080,060	$	3,279,449	$	10,359,509	$	5,859,264	$	3,065,245	$	8,924,509

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.
	These estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
Concentrations Credit Risk Policy [Policy Text Block]	'
	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer's financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required.
	Cash denominated in Euros with a US Dollar equivalent of $559,239 and $393,093 at December 31, 2013 and June 30, 2013, respectively, was held in accounts at financial institutions located in Europe.
	The following table summarizes accounts receivable concentrations:
		As of December 31,			As of June 30,
		2013			2013
	Customer A	23	%		11	%
	The following table summarizes revenue concentrations:
		Three Months Ended						Six Months Ended
		December 31,						December 31,
		2013			2012			2013		2012
	Customer A	21	%		23	%		16	%	16	%
	The following table summarizes vendor concentrations:
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Vendor A	28	%	26	%	21	%	22	%
	Vendor B		*	30	%		*	22	%
	Vendor C		*		*	12	%		*
	Vendor D		*		*	11	%		*
	* Less than 10%
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing three types of services to our customers: Article Galaxy, Reprints and ePrints, and Printing and Logistics services.
	Article Galaxy
	We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. The Company recognizes revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Reprints and ePrints
	We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content, however, when not prohibited by the content publisher, we use a third party to print Reprint orders delivered to North American customers, and TAAG to print Reprint orders delivered to mostly European customers. The Company recognizes revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Printing and Logistics Services
	We charge a transactional fee for each order of hard copy printed material. We are responsible for printing and delivering the order. Printing and Logistics services are exclusively performed by TAAG, our French operating subsidiary. The majority of TAAG’s customers are in France. Only a small percentage of the printing work performed by TAAG is for Reprint orders for North American operations delivered to mostly European customers. The Company recognizes revenue from printing services when the printed materials have been shipped to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations.  The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete.  Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	'
	Foreign Currency Translation
	The accompanying condensed consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the revenues and costs of TAAG are in Euros, and the costs of Reprints Desk Latin America are in Mexican pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.
Earnings Per Share, Policy [Policy Text Block]	'
	Net Income (Loss) Per Share
	Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock.  Diluted net income per share is computed similar to basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive securities had been issued.  Potentially dilutive securities include stock options and warrants.  The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.
	Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, excluding unvested restricted common stock.  Basic and diluted net loss per common share is the same for all periods presented with a net loss because all warrants and stock options outstanding are anti-dilutive.
	The calculation of basic and diluted net income (loss) per share is presented below:
		Three Months Ended						Six Months Ended
		December 31,						December 31,
		2013			2012			2013		2012
	Numerator:
	Net income (loss)	$	-446,556		$	178,319		$	-589,503	$	124,286
	Denominator:
	Weighted average shares outstanding (basic)		17,171,633			17,208,117			17,071,049		17,145,856
	Effect of diluted securities		-			-			-		29,807
	Weighted average shares outstanding (diluted)		17,171,633			17,208,117			17,071,049		17,175,663
	Net income (loss) per share:
	Basic	$	-0.03		$	0.01		$	-0.03	$	0.01
	Diluted	$	-0.03		$	0.01		$	-0.03	$	0.01
New accounting Pronouncements Policy [Policy Text Block]	'
	Recently Issued Accounting Pronouncements
	In March 2013, the FASB issued ASU 2013-05 Topic 830, “Foreign Currency Matters” (“ASU 2013-05”). ASU 2013-05 resolves the diversity in practice about whether Subtopic 810-10, Consolidation—Overall, or Subtopic 830-30, ASU 2013-05 applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business (other than a sale of in substance real estate or conveyance of oil and gas mineral rights) within a foreign entity. In addition, the amendments in this update resolve the diversity in practice for the treatment of business combinations achieved in stages (sometimes also referred to as step acquisitions) involving a foreign entity. ASU 2013-02 became effective for the company prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The Company does not expect the adoption of this guidance to have a material effect on the Company’s unaudited condensed consolidated financial statements.
	The FASB has issued Accounting Standards Update (ASU) No. 2013-04, Liabilities (Topic 405), “Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date.” ASU 2013-04 provides guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this ASU is fixed at the reporting date, except for obligations addressed within existing guidance in GAAP. The guidance requires an entity to measure those obligations as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The Company does not expect the adoption of this guidance to have a material impact on the Company’s unaudited condensed consolidated financial statements.
	In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of Unrecognized Tax Benefit When a Net Operating Loss Carryforward, A Similar Tax Loss, or a Tax Credit Carryforward Exists (A Consensus of the FASB Emerging Issues Task Force). ASU 2013-11 provides guidance on financial statement presentation of unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The FASB’s objective in issuing this ASU is to eliminate diversity in practice resulting from a lack of guidance on this topic in current GAAP. This ASU applies to all entities with unrecognized tax benefits that also have tax loss or tax credit carryforwards in the same tax jurisdiction as of the reporting date. This amendment is effective for public entities for fiscal years beginning after December 15, 2013 and interim periods within those years. The Company does not expect the adoption of this standard to have a material impact on the Company’s unaudited condensed consolidated financial position and results of operations.
	Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	The following table summarizes accounts receivable concentrations:
		As of December 31,			As of June 30,
		2013			2013
	Customer A	23	%		11	%
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	'
	The following table summarizes revenue concentrations:
		Three Months Ended						Six Months Ended
		December 31,						December 31,
		2013			2012			2013		2012
	Customer A	21	%		23	%		16	%	16	%
Fair Value, Concentration of Risk [Table Text Block]	'
	The following table summarizes vendor concentrations:
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Vendor A	28	%	26	%	21	%	22	%
	Vendor B		*	30	%		*	22	%
	Vendor C		*		*	12	%		*
	Vendor D		*		*	11	%		*
	* Less than 10%
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	The calculation of basic and diluted net income (loss) per share is presented below:
		Three Months Ended						Six Months Ended
		December 31,						December 31,
		2013			2012			2013		2012
	Numerator:
	Net income (loss)	$	-446,556		$	178,319		$	-589,503	$	124,286
	Denominator:
	Weighted average shares outstanding (basic)		17,171,633			17,208,117			17,071,049		17,145,856
	Effect of diluted securities		-			-			-		29,807
	Weighted average shares outstanding (diluted)		17,171,633			17,208,117			17,071,049		17,175,663
	Net income (loss) per share:
	Basic	$	-0.03		$	0.01		$	-0.03	$	0.01
	Diluted	$	-0.03		$	0.01		$	-0.03	$	0.01

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	6 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	The following table summarizes vested and unvested stock option activity:
			All Options						Vested Options					Unvested Options
			Shares			Weighted			Shares			Weighted		Shares		Weighted
						Average						Average				Average
						Exercise						Exercise				Exercise
						Price						Price				Price
	Outstanding at June 30, 2013			1,692,898			1.24			1,352,730			1.23		340,168		1.29
	Granted			191,472			1.8			7,400			1.8		184,072		1.8
	Options vesting			-			-			56,834			1.41		-56,834		1.41
	Exercised			-			-			-			-		-		-
	Forfeited/Cancelled			-			-			-			-		-		-
	Outstanding at December 31, 2013			1,884,370		$	1.3			1,416,964		$	1.24		467,406	$	1.48
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
	Additional information regarding stock options outstanding and exercisable as of December 31, 2013 is as follows:
	Option			Options			Remaining			Options
	Exercise			Outstanding			Contractual			Exercisable
	Price						Life (in years)
	$	1			347,000			5.41			347,000
		1.02			287,000			6.58			287,000
		1.07			53,898			8.79			42,231
		1.15			278,000			9.11			150,000
		1.25			32,000			9.13			-
		1.3			263,000			8.18			175,333
		1.5			380,000			4.06			380,000
		1.8			190,050			9.73			7,400
		1.85			24,000			9.39			-
		1.97			1,422			9.9			-
		3			15,000			7.04			15,000
		3.05			10,000			7.12			10,000
		3.65			3,000			7.22			3,000
	Total				1,884,370						1,416,964
Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options [Table Text Block]	'
	The following table summarizes warrant activity:
			Number of			Weighted
			Warrants			Average
						Exercise
						Price
	Outstanding, June 30, 2013			2,376,173			2.06
	Granted			-			-
	Exercised			-419,000			2
	Expired			-662,175			2
	Outstanding, December 31, 2013			1,294,998		$	2.11
	Exercisable, June 30, 2013			2,376,173		$	2.06
	Exercisable, December 31, 2013			1,294,998		$	2.11
Schedule Warrants Outstanding and Exercisable [Table Text Block]	'
	Additional information regarding warrants outstanding and exercisable as of December 31, 2013 is as follows:
	Warrant			Warrants			Remaining			Warrants
	Exercise Price			Outstanding			Contractual			Exercisable
							Life (in years)
	$	1.19			150,000			7.98			150,000
		1.25			150,000			1.85			150,000
		1.75			333,331			0.89			333,331
		2.25			266,667			0.97			266,667
		3			390,000			0.12			390,000
		3.5			2,500			2.5			2,500
		4			2,500			2.5			2,500
	Total				1,294,998						1,294,998
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	'
	The following table summarizes restricted common stock activity:
			Number of			Weighted
			Shares			Average
						Grant Date
						Fair Value
	Non-vested, June 30, 2013			33,939			1.85
	Granted			162,516			1.81
	Vested			-			-
	Forfeited			-			-
	Non-vested, December 31, 2013			196,455		$	1.82

Geographical_Information_Table

Geographical Information (Tables)	6 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	As of December 31, 2013, the Company had two reportable diverse geographical concentrations:  North American Operations, which consists of Reprints Desk and Reprints Desk Latin America, and TAAG, which operates in France.  Information related to these operating segments, net of eliminations, consists of the following for the periods below:
		Three Months Ended						Six Months Ended
		December 31, 2013						December 31, 2013
		North						North
		American		TAAG				American		TAAG
		Operations		(France)		Total		Operations		(France)		Total
	Revenue	$	7,383,148	$	2,239,231	$	9,622,379	$	14,000,578	$	4,199,522	$	18,200,100
	Cost of revenue		6,067,698		1,334,375		7,402,073		11,487,425		2,487,393		13,974,818
	Selling, general and administrative expenses		1,718,559		802,687		2,521,246		2,957,872		1,574,403		4,532,275
	Depreciation and amortization		50,770		70,194		120,964		98,321		139,994		238,315
	Income (loss) from operations	$	-453,879	$	31,975	$	-421,904	$	-543,040	$	-2,268	$	-545,308
		Three Months Ended						Six Months Ended
		December 31, 2012						December 31, 2012
		North		TAAG		Total		North		TAAG		Total
		American		(France)				American		(France)
		Operations						Operations
	Revenue	$	11,544,064	$	2,438,034	$	13,982,098	$	18,647,223	$	4,876,874	$	23,524,097
	Cost of revenue		9,848,155		1,375,242		11,223,397		15,685,344		2,923,208		18,608,552
	Selling, general and administrative expenses		1,242,750		1,171,951		2,414,701		2,365,597		2,039,814		4,405,411
	Depreciation and amortization		43,191		91,723		134,914		137,467		184,105		321,572
	Gain on sale of fixed assets		-		-		-		-8,500		1,621		-6,879
	Income (loss) from operations	$	409,968	$	-200,882	$	209,086	$	467,315	$	-271,874	$	195,441
		As of December 31, 2013						As of June 30, 2013
		North						North
		American		TAAG				American		TAAG
		Operations		(France)		Total		Operations		(France)		Total
	Current assets	$	6,835,895	$	2,254,451	$	9,090,346	$	5,536,474	$	2,147,249	$	7,683,723
	Property and equipment, net		145,057		554,629		699,686		189,596		641,635		831,231
	Intangible assets, net		89,410		-		89,410		123,482		-		123,482
	Other non-current assets		9,698		470,369		480,067		9,712		276,361		286,073
	Total assets	$	7,080,060	$	3,279,449	$	10,359,509	$	5,859,264	$	3,065,245		8,924,509
	Current liabilities	$	5,504,817	$	3,884,896	$	9,389,713	$	4,732,746	$	3,373,479		8,106,225
	Long term liabilities		-		280,574		280,574		-		504,104		504,104
	Equity		1,575,243		-886,021		689,222		1,126,518		-812,338		314,180
	Total liabilities and equity	$	7,080,060	$	3,279,449	$	10,359,509	$	5,859,264	$	3,065,245	$	8,924,509

Organization_Nature_of_Busines1

Organization, Nature of Business and Basis of Presentation (Details Textual) (USD $)	3 Months Ended		6 Months Ended			6 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Dec. 31, 2013	Jun. 30, 2013
						Taag [Member]	Taag [Member]
Organization Nature of Business and Basis of Presentation [Line Items]	'	'	'	'	'	'	'
Retained Earnings (Accumulated Deficit)	($14,581,741)	'	($14,581,741)	'	($13,992,238)	'	'
Operating Income (Loss)	-421,904	209,086	-545,308	195,441	'	-2,268	'
Working Capital Deficit	'	'	'	'	'	1,630,000	'
Total stockholders' equity (deficiency)	689,222	'	689,222	'	314,180	'	'
Net income (loss)	-446,556	178,319	-589,503	124,286	'	'	'
Net cash provided by operating activities	'	'	-123,941	1,101,401	'	'	'
Taxes Payable	'	'	'	'	'	325,000	'
Line of Credit Facility, Amount Outstanding	'	'	'	'	'	'	279,333
Payments to Acquire Loans Receivable	'	'	'	'	'	'	1,009,115
Capital Lease Obligations	'	'	'	'	'	'	$50,000

Summary_of_Significant_Account3

Summary of Significant Accounting Polices (Details) (Customer A [Member])	Dec. 31, 2013	Jun. 30, 2013
Customer A [Member]	'	'
Concentration Risk [Line Items]	'	'
Percentage Of Accounts Receivable Concentration	23.00%	11.00%

Summary_of_Significant_Account4

Summary of Significant Accounting Polices (Details 1) (Customer A [Member])	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Customer A [Member]	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'
Percentage Of Customer Revenue Concentration	21.00%	23.00%	16.00%	16.00%

Summary_of_Significant_Account5

Summary of Significant Accounting Polices (Details 2)	3 Months Ended				6 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2013		Dec. 31, 2012
Vendor A [Member]	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
Concentration Risk, Percentage	28.00%		26.00%		21.00%		22.00%
Vendor B [Member]	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
Concentration Risk, Percentage	'	[1]	30.00%		'	[1]	22.00%
Vendor C [Member]	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
Concentration Risk, Percentage	'	[1]	'	[1]	12.00%		'	[1]
Vendor D [Member]	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
Concentration Risk, Percentage	'	[1]	'	[1]	11.00%		'	[1]
[1]	Less than 10%

Summary_of_Significant_Account6

Summary of Significant Accounting Polices (Details 3) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Numerator:	'	'	'	'
Net income (loss)	($446,556)	$178,319	($589,503)	$124,286
Denominator:	'	'	'	'
Weighted average shares outstanding (basic)	17,171,633	17,208,117	17,071,049	17,145,856
Effect of diluted securities	0	0	0	29,807
Weighted average shares outstanding (diluted)	17,171,633	17,208,117	17,071,049	17,175,663
Earnings loss per share:	'	'	'	'
Basic	($0.03)	$0.01	($0.03)	$0.01
Diluted	($0.03)	$0.01	($0.03)	$0.01

Summary_of_Significant_Account7

Summary of Significant Accounting Policies (Details Textual) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Summary of Significant Accounting Policies [Line Items]	'	'
Cash, Fdic Insured Amount	$250,000	'
Europe Financial Institutions [Member]	'	'
Summary of Significant Accounting Policies [Line Items]	'	'
Deposits	$559,239	$393,093

Line_of_Credit_Details_Textual

Line of Credit (Details Textual) (USD $)	6 Months Ended		1 Months Ended	6 Months Ended
	Dec. 31, 2013	Jun. 30, 2013	Jul. 23, 2010	Dec. 31, 2013
			Silicon Valley Bank [Member]	Silicon Valley Bank [Member]
Line of Credit Facility [Line Items]	'	'	'	'
Line of Credit Facility, Amount Outstanding	'	'	$4,000,000	'
Line Of Credit Facility Expiration Date 1	'	'	31-Oct-15	'
Line Of Credit Facility Spread On Interest Rate	'	'	'	2.50%
Line Of Credit Facility Minimum Amount Outstanding	800,000	'	'	'
Line of Credit Facility, Interest Rate Description	'the prime rate plus 5.25%	'	'	'
Line of Credit Facility, Remaining Borrowing Capacity	$2,300,000	$2,000,000	'	'
Line of Credit Facility, Interest Rate at Period End	6.50%	'	'	'
Percentage Of Eligible Accounts Receivable On Line Of Credit	'	'	80.00%	'
Debt Instrument, Covenant Description	'	'	'	'Financial covenants are measured on North American operations only and include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2013, plus 50% of the dollar value of equity issuances after October 1, 2013 (reduced to 40% of the dollar value of equity issuances in connection with the exercise of warrants in November 2013) and the principal amount of subordinated debt.
Debt Instrument, Covenant Compliance	'	'	'	'The Company failed to comply with the tangible net worth covenant in December 2011 and July 2013. On both occasions the parties agreed to amend and reset the minimum tangible net worth required under the covenant.

Factor_Agreements_Details_Text

Factor Agreements (Details Textual)	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2013	Jun. 30, 2013
	USD ($)	USD ($)	Abn [Member]	Abn [Member]	Credit Cooperatif [Member]	Credit Cooperatif [Member]	Credit Cooperatif [Member]	Natixis [Member]	Natixis [Member]
			USD ($)	USD ($)	USD ($)	EUR (€)	USD ($)	USD ($)	USD ($)
Factor Agreements [Line Items]	'	'	'	'	'	'	'	'	'
Factor Arrangements Maximum Limit	'	'	'	'	$325,000	€ 250,000	'	'	'
Factor Interest Rate Spread	'	'	'	'	'	'	'	1.60%	'
Factor Interest Rate Percentage Year End	0.45%	'	'	'	5.00%	5.00%	'	1.80%	'
Due From Factor Current	'	'	0	165,971	'	'	'	12,434	0
Due To Factor Current	$171,415	$246,221	'	'	$171,415	'	$246,221	'	'

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	6 Months Ended
	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding beginning balance Shares	1,692,898
Granted Shares	191,472
Options vesting Shares	0
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	1,884,370
Outstanding beginning balance Weighted Average Exercise Price	$1.24
Granted Weighted Average Exercise Price	$1.80
Options vesting Weighted Average Exercise Price	$0
Exercised Weighted Average Exercise Price	$0
Forfeited/Cancelled Weighted Average Exercise Price	$0
Outstanding ending balance Weighted Average Exercise Price	$1.30
Unvested [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding beginning balance Shares	340,168
Granted Shares	184,072
Options vesting Shares	-56,834
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	467,406
Outstanding beginning balance Weighted Average Exercise Price	$1.29
Granted Weighted Average Exercise Price	$1.80
Options vesting Weighted Average Exercise Price	$1.41
Exercised Weighted Average Exercise Price	$0
Forfeited/Cancelled Weighted Average Exercise Price	$0
Outstanding ending balance Weighted Average Exercise Price	$1.48
Vested [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding beginning balance Shares	1,352,730
Granted Shares	7,400
Options vesting Shares	56,834
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	1,416,964
Outstanding beginning balance Weighted Average Exercise Price	$1.23
Granted Weighted Average Exercise Price	$1.80
Options vesting Weighted Average Exercise Price	$1.41
Exercised Weighted Average Exercise Price	$0
Forfeited/Cancelled Weighted Average Exercise Price	$0
Outstanding ending balance Weighted Average Exercise Price	$1.24

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1) (Stock Options [Member], USD $)	6 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding	1,884,370
Options Exercisable	1,416,964
Range One [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1
Options Outstanding	347,000
Options Outstanding Remaining Contractual Life (in years)	'5 years 4 months 28 days
Options Exercisable	347,000
Range Two [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.02
Options Outstanding	287,000
Options Outstanding Remaining Contractual Life (in years)	'6 years 6 months 29 days
Options Exercisable	287,000
Range Three [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.07
Options Outstanding	53,898
Options Outstanding Remaining Contractual Life (in years)	'8 years 9 months 14 days
Options Exercisable	42,231
Range Four [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.15
Options Outstanding	278,000
Options Outstanding Remaining Contractual Life (in years)	'9 years 1 month 10 days
Options Exercisable	150,000
Range Five [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.25
Options Outstanding	32,000
Options Outstanding Remaining Contractual Life (in years)	'9 years 1 month 17 days
Options Exercisable	0
Range Six [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.30
Options Outstanding	263,000
Options Outstanding Remaining Contractual Life (in years)	'8 years 2 months 5 days
Options Exercisable	175,333
Range Seven [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.50
Options Outstanding	380,000
Options Outstanding Remaining Contractual Life (in years)	'4 years 22 days
Options Exercisable	380,000
Range Eight [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.80
Options Outstanding	190,050
Options Outstanding Remaining Contractual Life (in years)	'9 years 8 months 23 days
Options Exercisable	7,400
Range Nine [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.85
Options Outstanding	24,000
Options Outstanding Remaining Contractual Life (in years)	'9 years 4 months 20 days
Options Exercisable	0
Range Ten [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.97
Options Outstanding	1,422
Options Outstanding Remaining Contractual Life (in years)	'9 years 10 months 24 days
Options Exercisable	0
Range Eleven [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$3
Options Outstanding	15,000
Options Outstanding Remaining Contractual Life (in years)	'7 years 14 days
Options Exercisable	15,000
Range Twelve [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$3.05
Options Outstanding	10,000
Options Outstanding Remaining Contractual Life (in years)	'7 years 1 month 13 days
Options Exercisable	10,000
RangeThirteenMember [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$3.65
Options Outstanding	3,000
Options Outstanding Remaining Contractual Life (in years)	'7 years 2 months 19 days
Options Exercisable	3,000

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (USD $)	6 Months Ended
	Dec. 31, 2013
Outstanding, Beginning balance Number of Warrants	2,376,173
Granted Number of Warrants	0
Exercised Number of Warrants	-419,000
Cancelled Number of Warrants	-662,175
Outstanding, Ending balance Number of Warrants	1,294,998
Exercisable, June 30, 2013 Number of Warrants	2,376,173
Exercisable, December 31, 2013 Number of Warrants	1,294,998
Outstanding, Beginning balance Weighted Average Exercise Price	$2.06
Granted Weighted Average Exercise Price	$0
Exercised Weighted Average Exercise Price	$2
Expired Weighted Average Expired Price	$2
Outstanding, Ending balance Weighted Average Exercise Price	$2.11
Exercisable, June 30, 2013 Weighted Average Exercise Price	$2.06
Exercisable, December 31, 2013 Weighted Average Exercise Price	$2.11

Stockholders_Equity_Details_3

Stockholders' Equity (Details 3) (Warrant [Member], USD $)	6 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Outstanding	1,294,998
Options Warrant Exercisable	1,294,998
Range One [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$1.19
Options Warrant Outstanding	150,000
Options Warrant Outstanding Remaining Contractual Life (in years)	'7 years 11 months 23 days
Options Warrant Exercisable	150,000
Range Two [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$1.25
Options Warrant Outstanding	150,000
Options Warrant Outstanding Remaining Contractual Life (in years)	'1 year 10 months 6 days
Options Warrant Exercisable	150,000
Range Three [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$1.75
Options Warrant Outstanding	333,331
Options Warrant Outstanding Remaining Contractual Life (in years)	'10 months 20 days
Options Warrant Exercisable	333,331
Range Four [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$2.25
Options Warrant Outstanding	266,667
Options Warrant Outstanding Remaining Contractual Life (in years)	'11 months 19 days
Options Warrant Exercisable	266,667
Range Five [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$3
Options Warrant Outstanding	390,000
Options Warrant Outstanding Remaining Contractual Life (in years)	'1 month 13 days
Options Warrant Exercisable	390,000
Range Six [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$3.50
Options Warrant Outstanding	2,500
Options Warrant Outstanding Remaining Contractual Life (in years)	'2 years 6 months
Options Warrant Exercisable	2,500
Range Seven [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Warrant Exercise Price	$4
Options Warrant Outstanding	2,500
Options Warrant Outstanding Remaining Contractual Life (in years)	'2 years 6 months
Options Warrant Exercisable	2,500

Stockholders_Equity_Details_4

Stockholdersb Equity (Details 4) (Restricted Stock [Member], USD $)	6 Months Ended
	Dec. 31, 2013
Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number Of Non-vested Shares, Beginning Balane ( in shares)	33,939
Granted, Number Of Shares	162,516
Vested, Number Of Shares	0
Forfeited, Number Of Shares	0
Number Of Non-vested Shares, Ending Balance (in shares)	196,455
Non-vested, Beginning Balance Weighted Average Grant date Fair Value	$1.85
Granted Weighted Average Grant date Fair Value	$1.81
Vested Weighted Average Grant date Fair Value	$0
Forfeited Weighted Average Grant date Fair Value	$0
Non-vested,Ending Balance Weighted Average Grant date Fair Value	$1.82

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)	1 Months Ended	6 Months Ended		0 Months Ended	6 Months Ended			0 Months Ended	6 Months Ended
	Nov. 22, 2013	Dec. 31, 2013	Dec. 31, 2012	Sep. 06, 2013	Dec. 31, 2013	Nov. 15, 2012	Nov. 15, 2012	Dec. 06, 2013	Dec. 31, 2013
				Restricted Stock [Member]	Restricted Stock [Member]	Minimum [Member]	Maximum [Member]	Consultant Services [Member]	Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	'	833,841	'	'	'	1,500,000	3,000,000	'	'
Share Based Compensation Warrants Fair Value	'	'	'	'	'	'	'	'	$317,333
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2	'	'6 years 11 months 1 day	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	'	'6 years 2 months 1 day	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	'	1,354,438	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	'	1,109,248	'	'	'	'	'	'	'
Fair value of vested stock options	'	131,678	110,406	'	'	'	'	'	'
Unallocated Share Based Compensation	'	407,706	'	'	'	'	'	'	'
Shares Issued During Period Share Exercise Of Warrants	'	'	'	'	'	'	'	'	419,000
Shares Issued During Period Value Exercise Of Warrants	'	838,000	'	'	'	'	'	'	838,000
Stock Issued During Period, Shares, Employee Stock Ownership Plan	'	'	'	150,833	'	'	'	'	'
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total	'	271,499	'	'	'	'	'	'	'
Restricted Stock Issued Price Per Share	'	$1.80	'	'	'	'	'	'	'
Stock Issued During Period, Shares, Restricted Stock Award, Gross	11,683	'	'	'	'	'	'	'	'
Stock Issued During Period, Value, Restricted Stock Award, Gross	23,016	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	'	'	'	'	47,168	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	'	247,347	'	'	'	'	'	'	'
Common Stock Market Price Per Share	$1.97	'	'	'	'	'	'	'	'
Stock Issued During Period, Shares, Issued For Services	'	'	'	'	'	'	'	2,748	'
Stock Issued During Period, Value, Issued For Services	'	$52,390	'	'	'	'	'	$5,222	'

Geographical_Information_Detai

Geographical Information (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenue	$9,622,379	$13,982,098	$18,200,100	$23,524,097	'
Cost of revenue	7,402,073	11,223,397	13,974,818	18,608,552	'
Selling, general and administrative expenses	2,521,246	2,414,701	4,532,275	4,405,411	'
Depreciation and amortization	120,964	134,914	238,315	321,572	'
Gain on sale of fixed assets	0	0	0	6,879	'
Income (loss) from operations	-421,904	209,086	-545,308	195,441	'
Current assets	9,090,346	'	9,090,346	'	7,683,723
Property and equipment, net	699,686	'	699,686	'	831,231
Intangible assets, net	89,410	'	89,410	'	123,482
Other non-current assets	480,067	'	480,067	'	286,073
Total assets	10,359,509	'	10,359,509	'	8,924,509
Current liabilities	9,389,713	'	9,389,713	'	8,106,225
Long term liabilities	280,574	'	280,574	'	504,104
Equity	689,222	'	689,222	'	314,180
Total liabilities and equity	10,359,509	'	10,359,509	'	8,924,509
North American Operations [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenue	7,383,148	11,544,064	14,000,578	18,647,223	'
Cost of revenue	6,067,698	9,848,155	11,487,425	15,685,344	'
Selling, general and administrative expenses	1,718,559	1,242,750	2,957,872	2,365,597	'
Depreciation and amortization	50,770	43,191	98,321	137,467	'
Gain on sale of fixed assets	'	0	'	-8,500	'
Income (loss) from operations	-453,879	409,968	-543,040	467,315	'
Current assets	6,835,895	'	6,835,895	'	5,536,474
Property and equipment, net	145,057	'	145,057	'	189,596
Intangible assets, net	89,410	'	89,410	'	123,482
Other non-current assets	9,698	'	9,698	'	9,712
Total assets	7,080,060	'	7,080,060	'	5,859,264
Current liabilities	5,504,817	'	5,504,817	'	4,732,746
Long term liabilities	0	'	0	'	0
Equity	1,575,243	'	1,575,243	'	1,126,518
Total liabilities and equity	7,080,060	'	7,080,060	'	5,859,264
TAAG [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenue	2,239,231	2,438,034	4,199,522	4,876,874	'
Cost of revenue	1,334,375	1,375,242	2,487,393	2,923,208	'
Selling, general and administrative expenses	802,687	1,171,951	1,574,403	2,039,814	'
Depreciation and amortization	70,194	91,723	139,994	184,105	'
Gain on sale of fixed assets	'	0	'	1,621	'
Income (loss) from operations	31,975	-200,882	-2,268	-271,874	'
Current assets	2,254,451	'	2,254,451	'	2,147,249
Property and equipment, net	554,629	'	554,629	'	641,635
Intangible assets, net	0	'	0	'	0
Other non-current assets	470,369	'	470,369	'	276,361
Total assets	3,279,449	'	3,279,449	'	3,065,245
Current liabilities	3,884,896	'	3,884,896	'	3,373,479
Long term liabilities	280,574	'	280,574	'	504,104
Equity	-886,021	'	-886,021	'	-812,338
Total liabilities and equity	$3,279,449	'	$3,279,449	'	$3,065,245